Stay updated with breaking news from Mdimune Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The days of simply accepting vision loss as just a part of the ageing process may soon be over after it was revealed scientists could be "one step closer" to developing a cure for age-related macular degeneration (AMD).
October xxth, 2022 – MDimune Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), announced a research collaboration agreement with the Clear Vision Research Lab (CVR Lab) at the Australian National University (ANU), experts in retinal degenerations.
MDimune, Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), enters into an MOU with SensoryCure to
Oslo, Norway and Seoul, South Korea 5 January, 2022 - PCI Biotech (OSE: PCIB), a Norwegian cancer focused biopharmaceutical company and MDimune Inc. ("MDimune"), a private South Korean biotech company
Investegate announcements from PCI Biotech Holding ASA, PCI Biotech and MDimune announce research collaboration agreement